Back

Residual cholesterol:a non-predictive marker for major adverse cardiovascular events in patients with intermediate coronary lesions: a large-scale multicenter study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Non-obstructive coronary disease: what's new in assessment and management Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jiayi Ren

2nd Hospital of Tianjin Medical University, Tianjin (China)

5 More presentations in this session

Presentation thumbnail
How late is too late? Influence of CMR timing in suspected MINOCA
Doctor G. Bisaccia (Chieti, IT)
Abstract Slides Video
Presentation thumbnail
Invasive assessment of coronary microvascular function in sepsis: The COronary Microcirculation and Troponin Elevation in Severe Sepsis (COMTESS)-study
Doctor S. Lorstad (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Procedural complications during intracoronary acetylcholine provocation testing in patients with cardiac arrest
Doctor K. Tateishi (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Adherence to consensus recommendations in the care of patients with spontaneous coronary artery dissection from the ANZ-SCAD registry
Doctor Q. Dang (Hamilton, NZ)
Abstract Slides Video
Presentation thumbnail
The influence of endothelial dysfunction and the prognosis in patients with myocardial infarction with non-obstructive coronary arteries.
Mr H. Kondo (Yokohama, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Non-obstructive coronary disease: what's new in assessment and management
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Inverse association between remnant cholesterol and MACCE in Japanese patients with CCS: insights from the clinical deep data accumulation system (CLIDAS)
thumbnail
Congress Presentation
Impact of glucose metabolism status on the relationship between remnant cholesterol and ischemic risk after percutaneous coronary intervention: a large-scale long-term cohort study from real-world
thumbnail
Congress Presentation
Sex-specific associations between remnant cholesterol and cardiovascular risk in patients undergoing percutaneous coronary intervention: a 5-year large-sample study from the real world

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources